EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Exploring the role of COX-2 in Alzheimer's disease: Potential therapeutic implications of COX-2 inhibitors

Nathalie Moussa, Ninar Dayoub

Saudi Pharmaceutical Journal · 2023-09 · 31 (9) · 101729

DOI: 10.1016/j.jsps.2023.101729 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Saudi Pharmaceutical Journal, 2023-09. Verfasst von Nathalie Moussa und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Chemistry and Drug Control, University of Manara, Latakia, Syria. Die Arbeit wurde bisher 89-mal zitiert (Crossref) und nennt 163 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This review highlights the potential role of cyclooxygenase-2 enzyme (COX-2) in the pathogenesis of Alzheimer's disease (AD) and the potential therapeutic use of non-steroidal anti-inflammatory drugs (NSAIDs) in the management of AD. In addition to COX-2 enzymes role in inflammation, the formation of amyloid plaques and neurofibrillary tangles in the brain, the review emphasizes that COXs-2 have a crucial role in normal synaptic activity and plasticity, and have a relationship with acetylcholine, tau protein, and beta-amyloid (Aβ) which are the main causes of Alzheimer's disease. Furthermore, the review points out that COX-2 enzymes have a relationship with kinase enzymes, including Cyclin Dependent Kinase 5 (CDK5) and Glycogen Synthase Kinase 3β (GSK3β), which are known to play a role in tau phosphorylation and are strongly associated with Alzheimer's disease. Therefore, the use of drugs like NSAIDs may be a hopeful approach for managing AD. However, results from studies examining the effectiveness of NSAIDs in treating AD have been mixed and further research is needed to fully understand the mechanisms by which COX-2 and NSAIDs may be involved in the development and progression of AD and to identify new therapeutic strategies.

Schlagwörter

Stichwörter der Autor:innen

Alzheimer's diseaseCDK5COX-2Drug discoveryNSAIDsTau phosphorylation

Autor:innen und Institutionen

  • Department of Pharmaceutical Chemistry and Drug Control, University of Manara, Latakia, Syria.
  • Faculty of Pharmacy, University of AL Andalus for Medical Science, Tartus, Syria.

Zitieren

APA

Moussa, N., & Dayoub, N. (2023). Exploring the role of COX-2 in Alzheimer's disease: Potential therapeutic implications of COX-2 inhibitors. Saudi Pharmaceutical Journal, 31(9), 101729. https://doi.org/10.1016/j.jsps.2023.101729

Vancouver

Moussa N, Dayoub N. Exploring the role of COX-2 in Alzheimer's disease: Potential therapeutic implications of COX-2 inhibitors. Saudi Pharmaceutical Journal. 2023;31(9):101729. doi:10.1016/j.jsps.2023.101729

BibTeX
@article{Moussa2023,
  author = {Moussa, Nathalie and Dayoub, Ninar},
  title = {Exploring the role of COX-2 in Alzheimer's disease: Potential therapeutic implications of COX-2 inhibitors},
  journal = {Saudi Pharmaceutical Journal},
  year = {2023},
  volume = {31},
  number = {9},
  pages = {101729},
  doi = {10.1016/j.jsps.2023.101729}
}
Kostenlos starten →